Dr. Nikita M. Maniar, MD

Dr. Maniar practices at Regents of the University of California Los Angeles in Santa Monica, California.

Dr. Maniar's NPI, 1225547722, was assigned on September 27, 2017. Dr. Maniar holds Illinois license 036158566.

Dr. Maniar's primary practice is Regents of the University of California Los Angeles, at 1801 Wilshire Blvd, Santa Monica, CA 90403 in Los Angeles County. The practice phone is (310) 391-7281.

Dr. Maniar's primary practice is Regents of the University of California Los Angeles in Santa Monica, California. Dr. Maniar is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Maniar to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maniar practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Maniar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Maniar is licensed in Illinois.

CMS data shows 34 Medicare services from Dr. Maniar across 1 procedure code in 2024, all of them office visits, for 62 Medicare patients. Medicare paid $3,017 for them.

CMS counts 62 Medicare patients who saw Dr. Maniar in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 66% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maniar's median patient age at 58, with 59% women.

In 2024, Dr. Maniar wrote 507 Medicare Part D claims for 97 patients. 91% of them were for generic drugs. CMS names the drug for 351 of them, across 16 drugs with 11 or more claims each, at $30,682 in total drug cost. In 2023, CMS named 227 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Maniar for performance year 2024, reported as part of a group. Dr. Maniar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maniar as offering telehealth.

Dmand AI links 1 paper to Dr. Maniar in 2025. Dr. Maniar's most frequent co-authors are Lucinda Bateman, MD, Hector F. Bonilla, MD and Leora Idit Horwitz, MD, MHS.

CMS Open Payments shows 35 general payments to Dr. Maniar from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $435.